Additional file 1 of Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy

Additional file 1: Supplementary Table 1. Direct target proteins (DTPs) and indirect target proteins (ITPs) of RGZ were analyzed using STITCH and STRING. Supplementary Table 2. Breast cancer angiogenesis regulatory genes. Supplementary Table 3. Targets of RGZ against breast cancer (BC) angiogenesis. Supplementary Table 4. MethSurv prognostic value of a single CpG from the FABP4, ADIPOQ, PPARG, PPARGC1A, CD36, and CREBBP in breast cancer.